Antimicrobial use and antimicrobial resistance: a population perspective.
about
Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usageAntibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenesEvolution in health and medicine Sackler colloquium: a public choice framework for controlling transmissible and evolving diseasesImpact of a United Kingdom-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change.The role of compensatory mutations in the emergence of drug resistanceAntibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trialDynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatmentWhen does overuse of antibiotics become a tragedy of the commons?Aggressive chemotherapy and the selection of drug resistant pathogensTargeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistanceSurveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based studyIntegrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive TreatmentAdvances in pharmacovigilance initiatives surrounding antimicrobial resistance-Indian perspective.Predispensing of antivirals to high-risk individuals in an influenza pandemicPre-dispensing of antivirals to high-risk individuals in an influenza pandemic.Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units.Effects of therapeutic ceftiofur administration to dairy cattle on Escherichia coli dynamics in the intestinal tract.High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.Antimicrobial use and indication-based prescribing among general practitioners in Eastern Croatia: comparison with data from the European Surveillance of Antimicrobial Consumption project.Outpatient antibiotic prescribing in the United States: 2000 to 2010.The evolution of plasmid-carried antibiotic resistance.A model of antibiotic-resistant bacterial epidemics in hospitals.Using interactive family science shows to improve public knowledge on antibiotic resistance: does it work?Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece.Strategies to combat antimicrobial resistanceImproving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis.The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.Efficacy of infection control interventions in reducing the spread of multidrug-resistant organisms in the hospital setting.The antimicrobial resistance crisis: causes, consequences, and management.Antimicrobial prescribing in the USA for adult acute pharyngitis in relation to treatment guidelines.Systematic review of the literature and evidence-based recommendations for antibiotic prophylaxis in trauma: results from an Italian consensus of experts.Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics.Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populationsA spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, BrasilImpact of outpatient antibiotic use on carriage of ampicillin-resistant Escherichia coli.The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapyEvidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments.Optimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistance. Insights from the society of infectious diseases pharmacists.Improving antibiotic adherence in treatment of acute upper respiratory infections: a quality improvement process.Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
P2860
Q21560993-980D605C-B99B-47A3-8DAD-39A5FA5660AFQ24600215-5324F73A-21C0-41FE-9EAB-A032C4EBC900Q24620815-24DA871D-6EDE-40A5-8A8D-84FA1E03BDBCQ27310224-72EBE2E4-F9BA-40EE-A73B-8A93543B64AFQ28469058-2B3B4822-42A4-4B4F-BB3B-87DE8E6D871FQ28476520-67C9FBF9-E606-4488-83E2-C1333ABB1936Q28478602-04524443-EF9E-4656-883B-CB3FD3D4E4D5Q28484246-044E44C2-6765-4F3D-A9FD-AEB638F5BEB9Q28533328-67813C3C-28DD-4EED-BE4E-5E59EF6DDFA4Q28534880-0EDF296D-2657-4C77-B9CC-68FEC65530E1Q28535024-F6B7AB6A-680B-4C44-B010-FA056B8ECB23Q28551361-E51F7041-AEE9-49B5-ADD8-5C2DBFE2368CQ30251437-A70221A5-24B6-4E68-938A-2B1518D945A0Q30383781-52AE785A-5A0C-4F2D-A530-8A34EB848DE0Q30385808-612FB0F4-9699-4964-9116-B8ABA8007DFFQ33319504-12F37EF8-3DD9-47E3-9B13-B33E546EE97DQ33372293-49365C67-6003-4DA0-87F6-9CADD93944CDQ33630862-42986932-27BB-4D80-BB8B-26BB4C5224BDQ33772725-21E2E84F-75BD-4B1B-BE98-D87662B4D04CQ33790880-F629EA26-D295-4490-8807-072C1FF26CEAQ33905942-F21CCBC1-5429-4190-BB13-49878CA8FB6EQ33947937-78E9BEAE-DC87-46C7-8204-21F66292F25DQ34097431-7A2A522D-AB1D-4D5F-871B-0946C3F47A25Q34107564-0AC8C857-4D89-4AC0-AF23-C1093C03BA1EQ34108467-292B5040-81EA-47B3-8F74-31D749A880E8Q34108542-0D84514C-B75E-4405-8B95-25B72D4E9380Q34141233-3A980D6C-57C6-41F9-8D17-49E2429AED1AQ34169916-22715821-3D80-491E-B58E-7ADA87A11979Q34192579-BF7F52B7-C837-45A0-BF99-E34AC38E4D63Q34297797-A2D33868-AB8B-4AEC-AD05-87C9889B3E70Q34550099-1F1A6831-4F58-449D-97D4-1856F6F2A90DQ34580194-711BEE15-735C-4492-8588-FD9274B97904Q34598512-23878187-C47B-442B-B4DC-DDD830EAD3B3Q34668087-A7292250-5BDE-4A65-B8F4-3D883E3B939DQ34737220-1B42D521-AAD5-4E32-AD44-8C0BFC20938FQ35092451-C4C5BB93-6F40-484D-98DF-53D17B76291AQ35558838-D6601073-5382-48DD-A844-60C3B5A68F52Q35616181-541C0CB0-0593-4F83-91C4-E2C8FCB77A97Q35762208-80BDECC0-E5AC-4D66-8018-18426FAC772FQ35873418-3BDC92E3-E227-432E-9AAE-93C3585FAC35
P2860
Antimicrobial use and antimicrobial resistance: a population perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antimicrobial use and antimicrobial resistance: a population perspective.
@en
Antimicrobial use and antimicrobial resistance: a population perspective.
@nl
type
label
Antimicrobial use and antimicrobial resistance: a population perspective.
@en
Antimicrobial use and antimicrobial resistance: a population perspective.
@nl
prefLabel
Antimicrobial use and antimicrobial resistance: a population perspective.
@en
Antimicrobial use and antimicrobial resistance: a population perspective.
@nl
P2860
P356
P1476
Antimicrobial use and antimicrobial resistance: a population perspective.
@en
P2093
Matthew H Samore
P2860
P304
P356
10.3201/EID0804.010312
P577
2002-04-01T00:00:00Z